Planning to improve global health: the next decade of tuberculosis control
Dermot Maher, Chris Dye, Katherine Floyd, Andrea Pantoja, Knut Lonnroth, Alasdair Reid, Eva Nathanson, Thad Pennas, Uli Fruth, Jane Cunningham, Heather Ignatius, Mario C Raviglione, Irene Koek, Marcos Espinal
Volume 85, Number 5, May 2007, 341-347
Box 1. The Stop TB Partnership’s working groups
| Working group | Purpose |
|---|---|
| DOTS expansion | To expand the coverage of DOTS, WHO’s recommended strategy for tuberculosis control |
| Multidrug-resistant TB | To integrate surveillance for drug resistance and the management of multidrug-resistant TB into routine components of TB control by providing access to diagnosis and treatment for all patients and engaging all health-care providers |
| TB/HIV | To reduce the global burden of HIV-related TB by implementing effective collaboration between TB and HIV programmes and communities, and by promoting evidence-based collaborative activities to control TB and HIV |
| Advocacy, communication and social mobilization | To achieve TB-free communities by using global and country-level advocacy, as well as communication and social mobilization techniques |
| New TB diagnostics | To implement research, advocacy and/or operational activities to develop tools to diagnose TB and to meet the aims of the partnership |
| New TB vaccines | To bring together the wide range of international groups with an interest in developing a TB vaccine; to accelerate the identification and introduction of the most effective vaccination strategy |
| New TB drugs | To ensure that scientists, academics, pharmaceutical companies, donors, multilateral agencies and patients are working together to speed the development of new drugs for TB |